Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000671016 | SCV000795953 | likely pathogenic | Alstrom syndrome | 2017-11-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000671016 | SCV001585252 | pathogenic | Alstrom syndrome | 2022-02-03 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with ALMS1-related conditions. This sequence change creates a premature translational stop signal (p.Leu55*) in the ALMS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALMS1 are known to be pathogenic (PMID: 17594715). This variant is present in population databases (rs755760721, gnomAD 0.009%). ClinVar contains an entry for this variant (Variation ID: 555236). For these reasons, this variant has been classified as Pathogenic. |